|

Triptorelin Clinical Trials

6 actively recruiting trials across 4 locations

▲ +1 trial since May 2026

Also known as: 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY 25650, AY-25650, AY25650 +8 more

Pipeline

Phase 2: 3Phase 3: 2

Top Sponsors

  • Santa Chiara Hospital1
  • SWOG Cancer Research Network1
  • SOLTI Breast Cancer Research Group1
  • Mayo Clinic1
  • ECOG-ACRIN Cancer Research Group1

Indications

  • Cancer6
  • Biochemically Recurrent Prostate Carcinoma2
  • Stage IVB Prostate Cancer AJCC v82
  • Prostate Cancer2
  • Premenopausal Breast Cancer1

Other2 trials

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
Phase 2
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Anchorage, Alaska1 trial

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Anchorage Associates in Radiation Medicine

Phase 3

Gilbert, Arizona1 trial

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Banner MD Anderson Cancer Center

Phase 3

Phoenix, Arizona1 trial

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Mayo Clinic in Arizona

Phase 2

Miami, Florida1 trial

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Miami Cancer Institute at Baptist Health, Inc.

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.